The first slide from the August 2025 issue of Journal Watch, titled "Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shock." For a more screenreader friendly version, the full issue PDF is at https://www.ishlt.org/docs/default-source/journal-watch/2025-08-journalwatch-cardiology.pdf.

The first study this month is from @jhlt.bsky.social and explores the safety and efficacy of #istaroxime in patients with pre- #cardiogenicshock due to #AcuteHF. It's reviewed by Sumita Barua of St. Vincent's in Sydney.

We'll highlight the rest of the studies later this month.